Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Research and Innovation Action · Running

COMPASS Cardio-Oncology Multidisciplinary Patient ASsistance Solution

Coordinator
King's College London, United Kingdom
Runs
1 March 2026 to 28 February 2031
Status
Running
EU funding
€28.7m
Total cost
€49.8m
Partners
64 organisations in 22 countries
Type
Research and Innovation Action
Grant agreement
101253264

What the project is doing

In the project's own words, from its summary on CORDIS.

The rise in cardiovascular disease among cancer patients and survivors, due to treatment side effects, poses a significant challenge to patient outcomes and healthcare systems. Managing cardiotoxicity is difficult due to its delayed onset and lack of reliable biomarkers, often requiring dose reduction or discontinuation of cancer treatment, which may compromise its effectiveness. The COMPASS project aims to optimize cardiovascular health for cancer patients and survivors through a comprehensive, patient-centered clinical pathway over five years.

It will advance cardio-oncology research by creating an international network and developing tools for better disease prediction, prevention, diagnosis, and management. The project focuses on integrating cardio-oncology care pathways, optimizing diagnostic biomarkers, and utilizing AI-supported imaging and wearable technologies for early detection and personalized treatment, while promoting sustainable healthcare delivery and reducing environmental impact.

COMPASS methodology includes three pillars: (i) Discovery of Novel Biomarkers and Parameters, (ii) AI Prediction Models and Clinical Decision Support System, and (iii) Improving Care Delivery and Patient Engagement. Activities across the program include Health Economics, Communication, Dissemination, Exploitation and Sustainability, and Ethics and Regulatory Aspects. This public private partnership of 51 academic and industrial partners will collaborate to translate scientific advancements into clinical applications, apply novel AI approaches, ensuring solutions are effective, meet patient needs, and align with European health policies and regulations.

Key stakeholders include clinicians, nurses, patients, payers, regulators, and industry actors. COMPASS aims to advance cardio-oncology research, reduce healthcare costs, and improve patient well-being through innovative tools, collaborative networks, and policy support. Ultimately, it aims to improve patient outcomes for both cancer and heart health.

Topics

Who is involved

OrganisationCityCountryRole
King's College LondonLondonUnited KingdomCoordinator
Ge Healthcare Austria GmbH & Co OgPfaffingAustriaThird party
Association Hospitaliere De Bruxelles-Centre Hospitalier Universitaire Jules BordetAnderlechtBelgiumParticipant
Cliniques Universitaires Saint-Luc ASBLBruxelles / BrusselBelgiumThird party
HictGentBelgiumParticipant
Katholieke Universiteit LeuvenLeuvenBelgiumParticipant
Themi Consulting BVGentBelgiumParticipant
Universite Catholique De LouvainLouvain La NeuveBelgiumParticipant
Arma Biosciences Inc.CalgaryCanadaParticipant
Aktiia SANeuchatelSwitzerlandParticipant
Csem Centre Suisse D'electronique Et De Microtechnique SA - Recherche Et DeveloppementNeuchatelSwitzerlandParticipant
F. Hoffmann-La Roche AGBaselSwitzerlandParticipant
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Ge Healthcare GmbHDusseldorfGermanyThird party
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbHNeuherbergGermanyParticipant
Spear UG (haftungsbeschrankt)MünchenGermanyParticipant
Universitatsklinikum HeidelbergHeidelbergGermanyParticipant
Aarhus UniversitetAarhus CDenmarkParticipant
Ge Healthcare Danmark A/sHerlevDenmarkThird party
Bridg OuTallinEstoniaParticipant
Keemilise Ja Bioloogilise Fuusika InstituutTallinnEstoniaParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Atrys Health SAMadridSpainParticipant
Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (f.s.p.)MadridSpainParticipant
ECG Médica S.L.ValenciaSpainParticipant
Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I SunyerBarcelonaSpainParticipant
Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones VicomtechDonostia San SebastianSpainParticipant
Fundacion Espanola De Oncologia RadioterapicaMadridSpainParticipant
Fundacion Para La Investigacion Biomedica Del Hospital Gregorio MaranonMadridSpainThird party
Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La PazMadridSpainThird party
Hospital Clinic De BarcelonaBarcelonaSpainThird party
Medtronic Iberica SAMadridSpainParticipant
Multiverse Computing SLSan SebastianSpainParticipant
Servicio Madrileno De SaludMadridSpainParticipant
Universidad De NavarraPamplonaSpainParticipant
Zabala Innovation Consulting SAMutilva Alta NavarraSpainParticipant
Ge Healthcare Finland OyHelsinkiFinlandThird party
Ge Medical Systems ScsBucFranceThird party
Gustave Roussy TransfertVillejuifFranceThird party
Institut Gustave RoussyVillejuifFranceParticipant
UnicancerParisFranceParticipant
Ge Healthcare Magyarorszag KftBudapestHungaryParticipant
Genomate Health Hungary KftBudapestHungaryParticipant
Syreon Kutato Intezet Korlatolt Felelossegu TarsasagBudapestHungaryParticipant
Észak-Pesti Centrumkórház - HonvédkórházBudapestHungaryParticipant
Global Heart Hub Company Limited by GuaranteeGalwayIrelandParticipant
Ge Medical Systems Israel LtdHaifaIsraelThird party
Datawizard SRLRomaItalyParticipant
Fondazione Policlinico Universitario Agostino Gemelli IrccsRomaItalyParticipant
Universita Della CalabriaArcavacata Di RendeItalyParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Fwdfaster Ai Research BVUtrechtNetherlandsParticipant
Stichting Amsterdam UmcAmsterdamNetherlandsParticipant
Ge Vingmed Ultrasound ASHortenNorwayThird party
Norges Teknisk-Naturvitenskapelige Universitet NTNUTrondheimNorwayParticipant
Universidade Do PortoPortoPortugalParticipant
Iaroca ABDomstenSwedenParticipant
Turkiye Bilimsel Ve Teknolojik Arastirma KurumuAnkaraTürkiyeParticipant
Ge Medical Systems LimitedChalfont St GilesUnited KingdomThird party
Guys and St Thomas' Nhs FoundationtrustLondonUnited KingdomParticipant

And 4 more organisations. Full list on CORDIS.

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI